Cite
HARVARD Citation
Tom, J. et al. (2022). Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*. Critical care medicine. 50 (3), pp. 398-409. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tom, J. et al. (2022). Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*. Critical care medicine. 50 (3), pp. 398-409. [Online].